3 Stocks to Buy if You Think the Economy Is Heading for a Recession

The article highlights Abbott Laboratories, Coca-Cola, and Walmart as recession-resistant stocks, emphasizing durable demand, defensive business models, and long dividend track records. Abbott has 54 straight years of dividend increases, Coca-Cola 64, and Walmart 53, reinforcing their appeal as income names in a higher-inflation, recession-risk environment. The piece is opinion-driven rather than event-driven, so near-term market impact should be limited.

Analysis

The common thread here is not just “defensiveness,” but pricing power plus necessity-driven demand, which matters more if inflation stays sticky and real wages keep grinding lower. ABT, KO, and WMT all sit in categories where consumers can downshift mix before they outright stop buying, so earnings resilience is likely to show up first in volume stability and second in margin preservation, especially versus discretionary retailers and branded consumer names with weaker shelf power. In a mild recession, these should outperform on relative earnings revisions more than absolute growth.

The second-order effect is that these names can become hidden beneficiaries of a demand-squeeze environment: when households trade down, WMT gains traffic, KO can reprice mix toward value formats, and ABT’s recurring healthcare consumption becomes less cyclical than the market often models. That likely pressures mid-tier grocers, regional pharmacy chains, and lower-quality medtech names that lack the same scale or brand moat. The more interesting dynamic is that “defensive dividend” trades can attract crowded capital late in the cycle, so the risk is not fundamental collapse but multiple compression if Treasury yields back up or recession odds fade.

The most important catalyst window is the next 1-3 quarters, when margin data will reveal whether these firms can offset slower topline with mix, procurement leverage, and selective pricing. If inflation re-accelerates, WMT and KO likely benefit faster than ABT because their demand elasticity is more immediately visible in basket behavior; if the economy softens sharply, ABT’s healthcare demand is the most insulated but also the least likely to rerate on narrative alone. Consensus is probably underestimating how much of the defensiveness is already owned, which limits upside unless there is a genuine macro scare.

Key Decisions for Investors

• Overweight WMT vs. XLY consumer discretionary basket for the next 3-6 months; best risk/reward if recession fears intensify because traffic and share gains should offset some margin pressure.
• Pair long KO / short PEP on a 1-2 quarter horizon; KO’s simpler defensive mix and cleaner dividend narrative should attract incrementally more capital if bond yields remain rangebound.
• Use ABT as a low-beta healthcare hedge, but only on pullbacks; prefer a 6-12 month call spread to express upside from diagnostics recovery without paying full multiple for safety.
• Avoid chasing the trio after a broad flight-to-quality rally; if 10Y yields move meaningfully higher, defensives can de-rate even as fundamentals hold, creating 5-10% downside without any earnings miss.
• For accounts needing income, build a staged long in WMT and KO over 2-4 weeks rather than all at once; these names are less about near-term torque and more about capital preservation plus 2-4% dividend carry.